Common Contracts

8 similar Sales Agreement contracts by BridgeBio Oncology Therapeutics, Inc., CapsoVision, Inc, Coherus Oncology, Inc., others

BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENT
Sales Agreement • September 1st, 2026 • BridgeBio Oncology Therapeutics, Inc. • Pharmaceutical preparations • New York

BridgeBio Oncology Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC and Cantor Fitzgerald & Co. (each an “Agent” and together, the “Agents”), as follows:

Golden Heaven Group Holdings Ltd. Class A Ordinary Shares (par value of $0.00001 each) Sales Agreement
Sales Agreement • August 31st, 2026 • Golden Heaven Group Holdings Ltd. • Services-miscellaneous amusement & recreation • New York

Golden Heaven Group Holdings Ltd., a Cayman Islands exempted company (the “Company”), confirms its agreement (this “Agreement”) with Craft Capital Management LLC (the “Agent”), as follows:

EDITAS MEDICINE, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENT
Sales Agreement • August 31st, 2026 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • New York

Editas Medicine, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows:

COHERUS ONCOLOGY, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENT
Sales Agreement • August 28th, 2026 • Coherus Oncology, Inc. • Biological products, (no disgnostic substances) • New York

Coherus Oncology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows:

Controlled Equity OfferingSM Sales Agreement
Sales Agreement • August 27th, 2026 • Healthy Choice Wellness Corp. • Retail-grocery stores • New York

Healthy Choice Wellness Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

Satellos Bioscience Inc. Common Shares SALES AGREEMENT
Sales Agreement • August 14th, 2026 • Satellos Bioscience Inc. • Pharmaceutical preparations • New York

Satellos Bioscience Inc., a corporation organized and existing under the laws of Canada (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows:

VEEA INC. Common Stock ($0.0001 par value per share) Sales Agreement
Sales Agreement • August 13th, 2026 • Veea Inc. • Services-computer integrated systems design • New York
CapsoVision, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement
Sales Agreement • August 13th, 2026 • CapsoVision, Inc • Electromedical & electrotherapeutic apparatus • New York

CapsoVision, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: